Status:
COMPLETED
Blood Pressure Reduction in Danish General Practice (BRIDGE)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To investigate the effect on blood pressure (BP) control in hypertensive patients using a combination of frequent home - and 24-h ambulatory blood pressure measurement (ABPM) in a Danish general pract...
Detailed Description
Also the beneficial effect of optimal blood pressure (BP) control is well established, sub-optimal blood pressure control is still highly prevalent in the hypertensive population. The purpose of this ...
Eligibility Criteria
Inclusion
- Inclusion criteria: 18 years or more, informed consent obtained, essential hypertension, able to use a home blood pressure apparatus, can cooperate to ambulatory blood pressure measurement. Exclusion criteria: Pregnancy, hypertension secondary to another disorder.
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00244660
Start Date
November 1 2005
End Date
June 1 2007
Last Update
January 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Frederiksberg Hospital
Frederiksberg F, Denmark, 2000